{
    "nctId": "NCT02316886",
    "officialTitle": "a Multinational, Multicenter, Prospective, Open-label, Active-treatment-controlled Randomized Trial: Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque_PREVENT Trial",
    "inclusionCriteria": "* Patients aged \u226518 years\n* Patients with suspected or known Coronary artery disease who are undergoing invasive cardiac catheterization\n* Patients with at least one significant stenosis (diameter stenosis \\>50%) with Fractional Flow Reserve (FFR) \\>0.80 and meeting two of the following criteria:\n\n  1. MLA(minimal luminal area)\\<4mm2\n  2. Plaque burden\\>70%\n  3. Large lipid-rich plaque on NIRS(Intracoronary Near-Infrared Spectroscopy), defined as MaxLCBI4mm\\>315\n  4. TCFA(thin-cap fibroatheroma) defined as fibrous cap thickness \\<65 \u03bcm and arc \\>90\u00b0 on optical coherence tomography (OCT) or \u226510% confluent necrotic core with \\>30\u00b0 abutting the lumen in three consecutive slices on Virtual-histology intravascular ultrasound (VH-IVUS)\n* Eligible for percutaneous coronary intervention with Absorb Bioresorbable Vascular Scaffold or Everolimus Eluting Stent\n* Reference vessel diameter 2.75-4.0\n* Lesion length \u2264 40mm\n* Willing and able to provide informed written consent\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* Patients for whom the preferred treatment is CABG(Coronary artery bypass grafting)\n* Patients with stented lesions\n* Patients with bypass graft lesions\n* Patients with three or more target lesions\n* Patients with two target lesions in the same coronary territory\n* Patients with heavily calcified or angulated lesions\n* Patients with bifurcation lesions requiring 2 stenting technique\n* Patients with contraindications to or planned discontinuation of dual antiplatelet therapy within 1 year\n* Patients with life expectancy \\<2 years\n* Patients with planned cardiac or major noncardiac surgery\n* Woman who are breastfeeding, pregnant or planning to become pregnant during the course of the study"
}